BR0116272A - Método de criação de um material de implantação a partir de tecido autogênico, alogênico ou xenogênico de mamìfero e material de implantação - Google Patents

Método de criação de um material de implantação a partir de tecido autogênico, alogênico ou xenogênico de mamìfero e material de implantação

Info

Publication number
BR0116272A
BR0116272A BR0116272-1A BR0116272A BR0116272A BR 0116272 A BR0116272 A BR 0116272A BR 0116272 A BR0116272 A BR 0116272A BR 0116272 A BR0116272 A BR 0116272A
Authority
BR
Brazil
Prior art keywords
implantation
creating
tissue
autogenic
allogeneic
Prior art date
Application number
BR0116272-1A
Other languages
English (en)
Inventor
Vettivetpillai Ketharanathan
Original Assignee
Vettivetpillai Ketharanathan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vettivetpillai Ketharanathan filed Critical Vettivetpillai Ketharanathan
Publication of BR0116272A publication Critical patent/BR0116272A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029—Radiation
    • A61L2/0035—Gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

"MéTODO DE CRIAçãO DE UM MATERIAL DE IMPLANTAçãO A PARTIR DE TECIDO AUTOGêNICO, ALOGêNICO OU XENOGêNICO DE MAMìFERO E MATERIAL DE IMPLANTAçãO". Trata-se de um método de criação de um material para implantação de tecido biológico e tecido biosintético obtido por engenharia e tecido biológico de origem autogênica, alogênica e xenogênica, adequado para implantação em seres humanos ou em animais como próteses cirúrgicas e vasculares. O material resultante inibe a calcificação in vivo e proporciona uma biomatriz porosa que não é suscetível a agiogênese e crescimento interno de tecido e que é adequado para adesão e retenção de células vivas transplantadas tais como células endoteliais, sem necessidade de revestimento protéico de matriz extracelular adicional. O método, que incorpora um aumento gradual de concentração de glutaraldeído desde 0% até não mais de 5% peso/volume em um pH que é gradualmente alterado de ácido para alcalino à temperatura ambiente, mantém a microarquitetura e o forro celular do material. Adicionalmente, a flexibilidade, maleabilidade e hemocompatibilidade juntamente com a resistência e a durabilidade podem ser variadas de acordo com a utilização final. O glutaraldeído penetra no material gradualmente e completamente, promovendo uma ligação cruzada dos componentes de colágeno do tecido.
BR0116272-1A 2000-12-20 2001-12-14 Método de criação de um material de implantação a partir de tecido autogênico, alogênico ou xenogênico de mamìfero e material de implantação BR0116272A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR2173A AUPR217300A0 (en) 2000-12-20 2000-12-20 Method of creating biological and biosynthetic material for implantation
PCT/AU2001/001619 WO2002049687A1 (en) 2000-12-20 2001-12-14 Method of creating biological and biosynthetic material for implantation

Publications (1)

Publication Number Publication Date
BR0116272A true BR0116272A (pt) 2004-02-17

Family

ID=3826207

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0116272-1A BR0116272A (pt) 2000-12-20 2001-12-14 Método de criação de um material de implantação a partir de tecido autogênico, alogênico ou xenogênico de mamìfero e material de implantação

Country Status (9)

Country Link
US (1) US7022348B2 (pt)
EP (1) EP1343543B1 (pt)
JP (1) JP4381680B2 (pt)
CN (1) CN100349620C (pt)
AU (1) AUPR217300A0 (pt)
BR (1) BR0116272A (pt)
CA (1) CA2432416C (pt)
ES (1) ES2414060T3 (pt)
WO (1) WO2002049687A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6866686B2 (en) * 2000-01-28 2005-03-15 Cryolife, Inc. Tissue graft
US8308797B2 (en) 2002-01-04 2012-11-13 Colibri Heart Valve, LLC Percutaneously implantable replacement heart valve device and method of making same
US20060045902A1 (en) * 2004-09-01 2006-03-02 Serbousek Jon C Polymeric wrap for in vivo delivery of osteoinductive formulations
MX2007007723A (es) * 2004-12-24 2007-12-07 Celxcel Pty Ltd Un biomaterial implantable y un metodo para producirlo.
JP5008284B2 (ja) * 2005-09-09 2012-08-22 グンゼ株式会社 組織再生用基材
US7544213B2 (en) * 2006-09-12 2009-06-09 Adams Jason P Inflatable hernia patch
US7909882B2 (en) * 2007-01-19 2011-03-22 Albert Stinnette Socket and prosthesis for joint replacement
US8317845B2 (en) * 2007-01-19 2012-11-27 Alexa Medical, Llc Screw and method of use
CA2800232C (en) 2010-03-01 2015-08-11 Colibri Heart Valve Llc Percutaneously deliverable heart valve and methods associated therewith
US9211361B2 (en) * 2010-03-15 2015-12-15 Kemal Schankereli Thin collagen tissue for medical device applications
WO2012006124A2 (en) 2010-06-28 2012-01-12 Vela Biosystems Llc Method and apparatus for the endoluminal delivery of intravascular devices
US9737400B2 (en) 2010-12-14 2017-08-22 Colibri Heart Valve Llc Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets
CN103796689B (zh) 2011-07-28 2017-05-31 哈博医疗科技有限公司 交联的人或动物组织产品及其制造方法和使用方法
JP6129867B2 (ja) * 2011-12-06 2017-05-17 エイオールティック イノベーションズ エルエルシーＡｏｒｔｉｃ Ｉｎｎｏｖａｔｉｏｎｓ Ｌｌｃ 血管内大動脈修復用デバイスおよびその使用方法
WO2013120082A1 (en) * 2012-02-10 2013-08-15 Kassab Ghassan S Methods and uses of biological tissues for various stent and other medical applications
WO2014123703A1 (en) * 2013-02-06 2014-08-14 Lifecell Corporation Methods for localized modification of tissue products
CN103272270B (zh) * 2013-05-22 2014-11-19 烟台正海生物技术有限公司 一种管状外科补片及其制备方法
CN103272271B (zh) * 2013-05-22 2014-11-05 烟台正海生物技术有限公司 用于治疗疝气的外科补片及其制备方法
CN103239760B (zh) * 2013-05-22 2014-11-05 烟台正海生物技术有限公司 防粘连外科补片及其制备方法
CN103272272B (zh) * 2013-05-22 2014-11-19 烟台正海生物技术有限公司 一种天然具孔皮肤补片及其制备方法
JP6173277B2 (ja) * 2014-08-27 2017-08-02 泰晴 野一色 人工血管及びその製造方法
CA3025501A1 (en) 2016-06-03 2017-12-07 Lifecell Corporation Methods for localized modification of tissue products
WO2019051476A1 (en) 2017-09-11 2019-03-14 Incubar, LLC SEALING DEVICE FOR USE AS A VASCULAR DUCT IMPLANT FOR REDUCING ENDOFUCTION
CN116983476B (zh) * 2023-07-28 2024-07-09 海迈医疗科技(苏州)有限公司 一种纳米结构低免疫原性生物型人工血管及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966401A (en) * 1974-07-01 1976-06-29 Hancock Laboratories Incorporated Preparing natural tissue for implantation so as to provide improved flexibility
AU516741B2 (en) * 1978-05-23 1981-06-18 Bio Nova Neo Technics Pty. Ltd. Vascular prostheses
JPS5534064A (en) 1978-08-31 1980-03-10 Nitta Gelatin Kk Production of collagen casing
JPS55118745A (en) 1979-03-09 1980-09-11 Mitsubishi Rayon Co Preparation of collagen sheettlike substance for medical treatment
WO1982000091A1 (en) * 1980-07-01 1982-01-21 V Ketharanathan Vascular prostheses
AU529411B2 (en) * 1980-07-01 1983-06-02 Wilkracht Pty. Ltd. Vascular prosthesis
US4472840A (en) * 1981-09-21 1984-09-25 Jefferies Steven R Method of inducing osseous formation by implanting bone graft material
FR2523810B1 (fr) * 1982-03-23 1988-11-25 Carpentier Alain Tissu biologique greffable et procede pour sa preparation
EP0160025B1 (en) * 1983-10-20 1989-12-13 KETHARANATHAN, Vettivetpillai Biomaterial
US4553974A (en) * 1984-08-14 1985-11-19 Mayo Foundation Treatment of collagenous tissue with glutaraldehyde and aminodiphosphonate calcification inhibitor
US4820626A (en) 1985-06-06 1989-04-11 Thomas Jefferson University Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself
WO1987002880A1 (en) 1985-11-13 1987-05-21 Domedica Pty. Limited Treatment of collagenous tissue
US4798611A (en) * 1986-10-14 1989-01-17 Hancock Jaffe Laboratories Enhancement of xenogeneic tissue
US5746775A (en) * 1988-04-01 1998-05-05 The Board Of Regent6S Of The University Of Michigan Method of making calcification-resistant bioprosthetic tissue
WO1994017841A1 (en) * 1993-02-01 1994-08-18 Baxter International Inc. Biological grafts having regionalized differences in cross-link density and their methods of manufacture
AU1931495A (en) 1994-03-14 1995-10-03 Cryolife, Inc. Treated tissue for implantation and preparation methods
US5595571A (en) * 1994-04-18 1997-01-21 Hancock Jaffe Laboratories Biological material pre-fixation treatment
ZA955010B (en) * 1994-06-15 1996-02-08 St Jude Medical Enhanced crosslinking of natural tissues
US5931969A (en) * 1994-07-29 1999-08-03 Baxter International Inc. Methods and apparatuses for treating biological tissue to mitigate calcification
AUPN174495A0 (en) 1995-03-15 1995-04-06 Ketharanathan, Vettivetpillai Surgical prostheses
US5782931A (en) 1996-07-30 1998-07-21 Baxter International Inc. Methods for mitigating calcification and improving durability in glutaraldehyde-fixed bioprostheses and articles manufactured by such methods

Also Published As

Publication number Publication date
US7022348B2 (en) 2006-04-04
WO2002049687A1 (en) 2002-06-27
CA2432416C (en) 2012-05-29
CN1494439A (zh) 2004-05-05
EP1343543A1 (en) 2003-09-17
EP1343543B1 (en) 2013-04-03
JP2004534559A (ja) 2004-11-18
JP4381680B2 (ja) 2009-12-09
EP1343543A4 (en) 2009-06-17
AUPR217300A0 (en) 2001-01-25
ES2414060T3 (es) 2013-07-18
CA2432416A1 (en) 2002-06-27
US20040030407A1 (en) 2004-02-12
CN100349620C (zh) 2007-11-21

Similar Documents

Publication Publication Date Title
BR0116272A (pt) Método de criação de um material de implantação a partir de tecido autogênico, alogênico ou xenogênico de mamìfero e material de implantação
RU2629809C2 (ru) Способ восстановления связки или сухожилия
Burke et al. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury.
US6214055B1 (en) Method and kit for rapid preparation of autologous tissue medical devices
US9456893B2 (en) Engineered tissue implants and methods of use thereof
Dunn et al. Development of fibroblast‐seeded ligament analogs for ACL reconstruction
Wahl et al. Controlling the processing of collagen-hydroxyapatite scaffolds for bone tissue engineering
ES2263185T3 (es) Biomaterial derivado de tejido hepatico de vertebrados.
DE69634013T2 (de) Verfahren und implantierbarer gegenstand zur förderung der endothelialisierung
AU727696B2 (en) Biopolymer foams for use in tissue repair and reconstruction
TWI432230B (zh) 組織支架
ES2278435T3 (es) Protesis con factores de crecimiento asociados.
ATE402002T1 (de) Elektroverarbeitetes kollagen
DE3751843D1 (de) Herstellung von körperorganen durch kontroliertes zellwachstum auf künstlicher matrix
KR960704562A (ko) 연조직 확대를 위한 주입가능한 조성물들
DE60018044D1 (de) Neue biomaterialien
HU225952B1 (en) Plaster for treating of joint surface cartilage
JP2015533598A (ja) 可撓性要素、特に天然または合成の靭帯または腱を骨に固定するための装置
Jitsuiki et al. Meniscal repair enhanced by an interpositional free synovial autograft: an experimental study in rabbits
AU2003238745A1 (en) Orthopaedic materials derived from keratin
WO2003099230A3 (en) Electroprocessed collagen and tissue engineering
Seo et al. The biocompatibility of silk scaffold for tissue engineered ligaments
ES2212285T3 (es) Tejido de la vaina dermica en la curacion de heridas.
Sedrakyan et al. Tissue engineering of a small hand phalanx with a porously casted polylactic acid–polyglycolic acid copolymer
ES2273695T3 (es) Endoprotesis recubierta de un principio activo con estabilizacion de larga duracion.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements